ARTICLE | Company News
GE imaging agent accepted for review in U.S., EU
January 9, 2013 1:24 AM UTC
GE Healthcare said FDA and EMA accepted for review regulatory applications for PET imaging agent [18F]-flutemetamol for the visual detection of beta amyloid in the brains of adult patients, which is a...